265 related articles for article (PubMed ID: 29152580)
1. Chromosomal Targeting by the Type III-A CRISPR-Cas System Can Reshape Genomes in
Guan J; Wang W; Sun B
mSphere; 2017; 2(6):. PubMed ID: 29152580
[TBL] [Abstract][Full Text] [Related]
2. Identification and functional study of type III-A CRISPR-Cas systems in clinical isolates of Staphylococcus aureus.
Cao L; Gao CH; Zhu J; Zhao L; Wu Q; Li M; Sun B
Int J Med Microbiol; 2016 Dec; 306(8):686-696. PubMed ID: 27600408
[TBL] [Abstract][Full Text] [Related]
3. An Endogenous Staphylococcus aureus CRISPR-Cas System Limits Phage Proliferation and Is Efficiently Excised from the Genome as Part of the SCC
Mikkelsen K; Bowring JZ; Ng YK; Svanberg Frisinger F; Maglegaard JK; Li Q; Sieber RN; Petersen A; Andersen PS; Rostøl JT; Høyland-Kroghsbo NM; Ingmer H
Microbiol Spectr; 2023 Aug; 11(4):e0127723. PubMed ID: 37404143
[TBL] [Abstract][Full Text] [Related]
4. Functional Characterization of Type III-A CRISPR-Cas in a Clinical Human Methicillin-R
Li Y; Mikkelsen K; Lluch I Grané O; Wang Z; Tang Y; Jiao X; Ingmer H; Høyland-Kroghsbo NM; Li Q
CRISPR J; 2021 Oct; 4(5):686-698. PubMed ID: 34558981
[TBL] [Abstract][Full Text] [Related]
5. The CRISPR Spacer Space Is Dominated by Sequences from Species-Specific Mobilomes.
Shmakov SA; Sitnik V; Makarova KS; Wolf YI; Severinov KV; Koonin EV
mBio; 2017 Sep; 8(5):. PubMed ID: 28928211
[TBL] [Abstract][Full Text] [Related]
6. Characterization of 67 Confirmed Clustered Regularly Interspaced Short Palindromic Repeats Loci in 52 Strains of
Wang Y; Mao T; Li Y; Xiao W; Liang X; Duan G; Yang H
Front Microbiol; 2021; 12():736565. PubMed ID: 34751223
[No Abstract] [Full Text] [Related]
7. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
[TBL] [Abstract][Full Text] [Related]
8. Identification and Characterization of the CRISPR/Cas System in
Cruz-López EA; Rivera G; Cruz-Hernández MA; Martínez-Vázquez AV; Castro-Escarpulli G; Flores-Magallón R; Vázquez K; Cruz-Pulido WL; Bocanegra-García V
Front Microbiol; 2021; 12():656996. PubMed ID: 34149645
[TBL] [Abstract][Full Text] [Related]
9. Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.
Maniv I; Jiang W; Bikard D; Marraffini LA
J Bacteriol; 2016 Jan; 198(6):941-50. PubMed ID: 26755632
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the features of 45 identified CRISPR loci in 32 Staphylococcus aureus.
Yang S; Liu J; Shao F; Wang P; Duan G; Yang H
Biochem Biophys Res Commun; 2015 Aug; 464(3):894-900. PubMed ID: 26188514
[TBL] [Abstract][Full Text] [Related]
11. Anti-cas spacers in orphan CRISPR4 arrays prevent uptake of active CRISPR-Cas I-F systems.
Almendros C; Guzmán NM; García-Martínez J; Mojica FJ
Nat Microbiol; 2016 Jun; 1(8):16081. PubMed ID: 27573106
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas systems and RNA-guided interference.
Barrangou R
Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
[TBL] [Abstract][Full Text] [Related]
13. Genetic characterization of antiplasmid immunity through a type III-A CRISPR-Cas system.
Hatoum-Aslan A; Maniv I; Samai P; Marraffini LA
J Bacteriol; 2014 Jan; 196(2):310-7. PubMed ID: 24187086
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands.
Vercoe RB; Chang JT; Dy RL; Taylor C; Gristwood T; Clulow JS; Richter C; Przybilski R; Pitman AR; Fineran PC
PLoS Genet; 2013 Apr; 9(4):e1003454. PubMed ID: 23637624
[TBL] [Abstract][Full Text] [Related]
15. Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus.
Majumdar S; Zhao P; Pfister NT; Compton M; Olson S; Glover CV; Wells L; Graveley BR; Terns RM; Terns MP
RNA; 2015 Jun; 21(6):1147-58. PubMed ID: 25904135
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-based screening of genomic island excision events in bacteria.
Selle K; Klaenhammer TR; Barrangou R
Proc Natl Acad Sci U S A; 2015 Jun; 112(26):8076-81. PubMed ID: 26080436
[TBL] [Abstract][Full Text] [Related]
17. Correlation between type IIIA CRISPR-Cas system and SCCmec in Staphylococcus epidermidis.
Zhu T; Zhao Y
Arch Microbiol; 2021 Dec; 203(10):6275-6286. PubMed ID: 34668031
[TBL] [Abstract][Full Text] [Related]
18. Friendly Fire: Biological Functions and Consequences of Chromosomal Targeting by CRISPR-Cas Systems.
Heussler GE; O'Toole GA
J Bacteriol; 2016 May; 198(10):1481-6. PubMed ID: 26929301
[TBL] [Abstract][Full Text] [Related]
19. The subtype I-F CRISPR-Cas system influences pathogenicity island retention in Pectobacterium atrosepticum via crRNA generation and Csy complex formation.
Richter C; Fineran PC
Biochem Soc Trans; 2013 Dec; 41(6):1468-74. PubMed ID: 24256239
[TBL] [Abstract][Full Text] [Related]
20. Occurrence and Diversity of CRISPR-Cas Systems in the Genus Bifidobacterium.
Briner AE; Lugli GA; Milani C; Duranti S; Turroni F; Gueimonde M; Margolles A; van Sinderen D; Ventura M; Barrangou R
PLoS One; 2015; 10(7):e0133661. PubMed ID: 26230606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
